Published in J Pharm Sci on August 01, 1978
Binding of drugs by albumin and plasma protein. J Pharm Sci (1977) 1.31
Effect of pH on the binding of theophylline to serum proteins. Am Rev Respir Dis (1979) 1.18
Pharmacokinetics and bioavailability of hydromorphone following intravenous and oral administration to human subjects. J Clin Pharmacol (1981) 1.07
Carbon-13 NMR spectroscopy of red blood cell suspensions. Biochem Biophys Res Commun (1972) 1.04
Intraoperative serum and tissue activity of cefazolin and cefoxitin. Arch Surg (1985) 1.01
Generation of particulate matter in large-volume parenteral containers. J Pharm Sci (1974) 0.96
Plasma levels of clobazam after three oral dosage forms in health subjects. J Clin Pharmacol (1978) 0.95
Absorption of polyethylene glycol after administration of a PEG-electrolyte lavage solution. Clin Pharm (1986) 0.94
Intraoperative serum concentrations of cefazolin and cefoxitin administered preoperatively at different times. Clin Pharm (1984) 0.92
Effect of various factors on the amount of plasticizer in intravenous solutions packaged in flexible bags. Am J Hosp Pharm (1977) 0.90
Glass-rubber transitions of cellulosic polymers by dynamic mechanical analysis. J Pharm Sci (1990) 0.90
Mechanism of misoprostol stabilization in hydroxypropyl methylcellulose. Adv Exp Med Biol (1991) 0.86
Oral delivery of a renin inhibitor compound using emulsion formulations. Pharm Res (1992) 0.86
Sterically stabilized liposomes in cancer therapy and gene delivery. Curr Opin Mol Ther (1999) 0.83
Plasma level studies of penbutolol after oral dose in man. J Clin Pharmacol (1977) 0.83
Comparison of graphical and computerized methods for calculating binding parameters for two strongly bound drugs to human serum albumin. J Pharm Sci (1976) 0.83
Carbon-13 nuclear magnetic resonance spectroscopy of cobalamins and cobinamides selectively enriched with carbon-13. J Am Chem Soc (1973) 0.82
Letter: Particulate matter in polyvinyl chloride intravenous bags. N Engl J Med (1973) 0.82
Solubility of amino acids in pure solvent systems. J Pharm Sci (1971) 0.81
Clearance of serum cortisol in suckled and nonsuckled postpartum beef cows. J Anim Sci (1981) 0.80
Cephalosporins for surgical prophylaxis: computer projections of intraoperative availability. South Med J (1985) 0.80
Intraoperative ceforanide pharmacokinetics and protein binding. Antimicrob Agents Chemother (1985) 0.79
Emulsion formulations of testosterone for nasal administration. J Microencapsul (1998) 0.79
Development of a new non-surgical perfusion technique for evaluation of nasal drug delivery. Pharmazie (1994) 0.78
Development and evaluation of nasal formulations of ketorolac. Drug Deliv (2001) 0.77
Interaction of dantrolene sodium with human serum albumin. J Pharm Sci (1976) 0.76
Enhancement of nasal delivery of a renin inhibitor in the rat using emulsion formulations. Pharm Res (1992) 0.76
Effect of cyclosporine A formulations on bovine corneal absorption: ex-vivo study. J Microencapsul (1997) 0.76
The influence of the enhancer dimyristoylphosphatidylglycerol and formulation factors on the nasal absorption of salmon calcitonin. Drug Deliv (1998) 0.76
Evaluation of the performance of controlled release dosage forms of ticlopidine using in vitro intestinal permeability and computer simulations. J Drug Target (1994) 0.75
Plasma levels of clobazam after 10-, 20-, and 40-mg tablet doses in healthy subjects. J Clin Pharmacol (1980) 0.75
Comparison of dissolution profiles of tablets and capsules from the USP, Levy, and magnetic basket methods. J Pharm Sci (1974) 0.75
Solid-state interaction of magnesium oxide and ibuprofen to form a salt. Pharm Res (1989) 0.75
Interaction of the antimalarial alpha-dibutylaminomethyl-2,6-bis(trifluoromethylphenyl)-4-pyridinemethanol with human serum albumin. J Pharm Sci (1979) 0.75
Effect of bile salts on partitioning behavior and GI absorption of a quaternary ammonium compound, isopropamide iodide. J Pharm Sci (1973) 0.75
Binding of xanthine derivatives to human serum albumin as a function of pH. Acta Pharm Suec (1981) 0.75
Pharmacokinetics of tiazofurin in dogs. Biopharm Drug Dispos (1987) 0.75
Bioavailability and dissolution parameters of seven lithium carbonate products. J Pharm Sci (1979) 0.75
A new method for the determination of the site binding constant of each species of a partially ionized drug. Acta Pharm Suec (1980) 0.75
Circular dichroic examination of the interaction of some planar acidic drugs with tryptophan-modified human serum albumin. J Pharm Pharmacol (1981) 0.75
A study of the effect of some drugs on the dissolution rate of nitrofurantoin. Pharmazie (1980) 0.75
Influence of respiratory acidosis and alkalosis on volume of distribution of theophylline in dogs. Res Commun Chem Pathol Pharmacol (1979) 0.75
An unbiased method for estimating binding parameters in a non-cooperative binding process. Biochim Biophys Acta (1974) 0.75
Aggregation of dantrolene to human serum albumin. J Pharm Sci (1978) 0.75
Correlation of aspirin excretion with parameters from different dissolution methods. J Pharm Sci (1978) 0.75
beta-Lipoproteins: possible plasma transport proteins for basic drugs. J Pharm Sci (1977) 0.75
Monitoring tablet dissolution with a sodium ion-selective glass electrode. J Pharm Sci (1971) 0.75
Some quantitative investigations of the binding to and the displacement of bishydroxycoumarin from human serum albumin. Biochem Pharmacol (1975) 0.75
Liquid chromatography in pharmaceutical analysis VI: determination of dantrolene sodium in a dosage form. J Pharm Sci (1977) 0.75
Plasma level profiles and clinical response of penbutolol after three different single oral doses in man. J Clin Pharmacol (1979) 0.75
Cardiac rhythm disturbances during fiberoptic bronchoscopy: a prospective study. J Thorac Cardiovasc Surg (1979) 0.75
Ketorolac tromethamine and ketoprofen suppositories: release profiles and bioavailability of a cocoa butter base formula in rabbits. Int J Pharm Compd (2013) 0.75
Evaluation of magnetic basket dissolution apparatus. I. Differences in tablet formulations. J Pharm Sci (1973) 0.75
Bioavailability of regular and controlled-release chlorpheniramine products. J Pharm Sci (1982) 0.75
Importance of considering variables when using magnetic basket dissolution apparatus. J Pharm Sci (1973) 0.75
Effect of albumin conformation on binding of phenylbutazone and oxyphenbutazone to human serum albumin. J Pharm Sci (1982) 0.75
Sodium-ion electrode: continuous monitoring of tablet dissolution via flowing streams. J Pharm Sci (1973) 0.75
Coating charcoal with polyacrylate-polymethacrylate copolymer for haemoperfusion. II. Drug removal and polymer compatibility studies. J Microencapsul (1994) 0.75
Letter: Plasticizer delivered from polyvinyl chloride intravenous bags. N Engl J Med (1976) 0.75
Ultrasonic degradation of aspirin in mixed solvent systems. J Pharm Sci (1969) 0.75
Resistance of large-volume parenteral containers to forced microbial contamination. J Pharm Sci (1973) 0.75
Correlation of urinary excretion with in vitro dissolution using several dissolution methods for hydrochlorothiazide formulations. J Pharm Sci (1979) 0.75
Physical state of misoprostol in hydroxypropyl methylcellulose films. Pharm Res (1990) 0.75
Solubility of amino acids in mixed solvent systems. J Pharm Sci (1971) 0.75
Carbon-13 nuclear magnetic resonance and infrared spectroscopic studies of 13 CO binding to rabbit hemoglobin. J Am Chem Soc (1973) 0.75
The absorption and distribution of isopropamide iodide in the rat. J Pharm Pharmacol (1973) 0.75
Indomethacin release from silicone rubber: a suggested method for continuous inhibition of prostaglandin synthesis. Res Commun Chem Pathol Pharmacol (1975) 0.75
Examination of blood clobazam levels and several pupillary measures in humans. J Pharm Sci (1979) 0.75
Comparison of availability of ions from sodium salicylate and salicylic acid tablets. J Pharm Sci (1974) 0.75
Particulate contamination and stability of three additives in 0.9% sodium chloride injection in plastic and glass large-volume containers. Am J Hosp Pharm (1975) 0.75
Blood levels following multiple oral dosing of chlorpheniramine conventional and controlled release preparations. Biopharm Drug Dispos (1982) 0.75
Human plasma levels of propranolol: fluorometric measurement in a hydrosolvatic system. J Pharm Sci (1980) 0.75
The chemical synthesis and nuclear magnetic resonance spectroscopy of adenosylcobalamin selectively enriched with carbon-13. Biochemistry (1974) 0.75
Coating charcoal with polyacrylate-polymethacrylate copolymer for haemoperfusion. I: Fabrication and evaluation. J Microencapsul (1992) 0.75
Pharmacodynamics of acute intranasal administration of verapamil: comparison with i.v. and oral administration. Biopharm Drug Dispos (1986) 0.75
Delivery of plasticizer from standard intravenous-administration sets. N Engl J Med (1978) 0.75
In vivo and in vitro availability of commercial vitamin C tablets. Pahlavi Med J (1977) 0.75
Preliminary investigations of intrinsic and extrinsic optical activity as purity criterion for human serum albumins. J Pharm Sci (1975) 0.75
Scatchard plot analysis of ligand--erythrocyte interactions. J Pharm Sci (1978) 0.75
Coating charcoal with polyacrylate-polymethacrylate copolymer for haemoperfusion. III: The effect of the coat thickness on the adsorptioncapacity of the coated charcoal and its adsorptivity to small and middle size molecules. J Microencapsul (1996) 0.75
Biopharmaceutical evaluation of a tablet dosage form made from ethyl cellulose encapsulated aspirin particles. J Microencapsul (1991) 0.75
Effect of bile salts on partitioning and oral toxicity of the bisquaternary ammonium drug decamethonium bromide. J Pharm Sci (1974) 0.75
Prazosin alters free and total plasma digoxin levels in dogs. Am Heart J (1985) 0.75
Age-related changes in the pharmacodynamics of verapamil. Am Heart J (1985) 0.75
Liquid chromatography in pharmaceutical analysis VII: determination of dantrolene sodium in biological fluids. J Pharm Sci (1977) 0.75
The effect of the anion on the absorption of tetracycline from the rat stomach. J Pharm Pharmacol (1970) 0.75
Dynamic dialysis in drug-erythrocyte interactions. J Pharm Sci (1979) 0.75